369 related articles for article (PubMed ID: 30303592)
1. Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence.
Arena A; Zimmer TS; van Scheppingen J; Korotkov A; Anink JJ; Mühlebner A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Vezzani A; Baayen JC; Idema S; Iyer AM; Perluigi M; Mills JD; van Vliet EA; Aronica E
Brain Pathol; 2019 May; 29(3):351-365. PubMed ID: 30303592
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Sun FJ; Zhang CQ; Chen X; Wei YJ; Li S; Liu SY; Zang ZL; He JJ; Guo W; Yang H
J Neuroinflammation; 2016 Apr; 13(1):85. PubMed ID: 27095555
[TBL] [Abstract][Full Text] [Related]
3. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
[TBL] [Abstract][Full Text] [Related]
4. Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformations.
Zimmer TS; Ciriminna G; Arena A; Anink JJ; Korotkov A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Baayen JC; Idema S; Rensing NR; Wong M; Mills JD; van Vliet EA; Aronica E
Neuropathol Appl Neurobiol; 2020 Oct; 46(6):546-563. PubMed ID: 31869431
[TBL] [Abstract][Full Text] [Related]
5. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
Talos DM; Sun H; Kosaras B; Joseph A; Folkerth RD; Poduri A; Madsen JR; Black PM; Jensen FE
Ann Neurol; 2012 Apr; 71(4):539-51. PubMed ID: 22447678
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.
van Scheppingen J; Broekaart DW; Scholl T; Zuidberg MR; Anink JJ; Spliet WG; van Rijen PC; Czech T; Hainfellner JA; Feucht M; Mühlebner A; van Vliet EA; Aronica E
J Neuroinflammation; 2016 Aug; 13(1):202. PubMed ID: 27566410
[TBL] [Abstract][Full Text] [Related]
7. Downregulated formyl peptide receptor 2 expression in the epileptogenic foci of patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Huang K; Wang Z; He Z; Li Y; Li S; Shen K; Zhu G; Liu Z; Lv S; Zhang C; Yang H; Yang X; Liu S
Immun Inflamm Dis; 2022 Nov; 10(11):e706. PubMed ID: 36301030
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress.
Zimmer TS; Korotkov A; Zwakenberg S; Jansen FE; Zwartkruis FJT; Rensing NR; Wong M; Mühlebner A; van Vliet EA; Aronica E; Mills JD
Brain Pathol; 2021 Sep; 31(5):e12949. PubMed ID: 33786950
[TBL] [Abstract][Full Text] [Related]
9. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
Nguyen LH; Mahadeo T; Bordey A
J Neurosci; 2019 Apr; 39(14):2762-2773. PubMed ID: 30700531
[TBL] [Abstract][Full Text] [Related]
10. Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex.
Guo W; Zhang CQ; Shu HF; Yang MH; Yin Q; Yang H
J Mol Neurosci; 2013 May; 50(1):7-13. PubMed ID: 22752548
[TBL] [Abstract][Full Text] [Related]
11. [Expression of autophagy-related proteins in malformations of cortical development].
Chen S; Piao Y; Fu Y; Li Z; Liu C; Lu D
Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):305-9. PubMed ID: 26178210
[TBL] [Abstract][Full Text] [Related]
12. Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with
Wang Z; Huang K; Yang X; Shen K; Yang L; Ruan R; Shi X; Wang M; Zhu G; Yang M; Zhang C; Lv S; Yang H; Fan X; Liu S
Brain Pathol; 2021 Mar; 31(2):346-364. PubMed ID: 33314369
[TBL] [Abstract][Full Text] [Related]
13. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
Boer K; Lucassen PJ; Spliet WG; Vreugdenhil E; van Rijen PC; Troost D; Jansen FE; Aronica E
Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
[TBL] [Abstract][Full Text] [Related]
14. Characteristic expression of p57/Kip2 in balloon cells in focal cortical dysplasia.
Kimura T; Kitaura H; Masuda H; Kameyama S; Saito Y; Sugai K; Otsuki T; Nakazawa A; Morota N; Yamamoto T; Iida K; Nakagawa M; Mizuno T; Takahashi H; Kakita A
Neuropathology; 2015 Oct; 35(5):401-9. PubMed ID: 25950494
[TBL] [Abstract][Full Text] [Related]
15. Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.
Scholl T; Mühlebner A; Ricken G; Gruber V; Fabing A; Samueli S; Gröppel G; Dorfer C; Czech T; Hainfellner JA; Prabowo AS; Reinten RJ; Hoogendijk L; Anink JJ; Aronica E; Feucht M
Brain Pathol; 2017 Nov; 27(6):770-780. PubMed ID: 27750396
[TBL] [Abstract][Full Text] [Related]
16. Abnormal maturation and differentiation of neocortical neurons in epileptogenic cortical malformation: unique distribution of layer-specific marker cells of focal cortical dysplasia and hemimegalencephaly.
Arai A; Saito T; Hanai S; Sukigara S; Nabatame S; Otsuki T; Nakagawa E; Takahashi A; Kaneko Y; Kaido T; Saito Y; Sugai K; Sasaki M; Goto Y; Itoh M
Brain Res; 2012 Aug; 1470():89-97. PubMed ID: 22759905
[TBL] [Abstract][Full Text] [Related]
17. Cell injury and premature neurodegeneration in focal malformations of cortical development.
Iyer A; Prabowo A; Anink J; Spliet WG; van Rijen PC; Aronica E
Brain Pathol; 2014 Jan; 24(1):1-17. PubMed ID: 23586324
[TBL] [Abstract][Full Text] [Related]
18. PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia.
Jansen LA; Mirzaa GM; Ishak GE; O'Roak BJ; Hiatt JB; Roden WH; Gunter SA; Christian SL; Collins S; Adams C; Rivière JB; St-Onge J; Ojemann JG; Shendure J; Hevner RF; Dobyns WB
Brain; 2015 Jun; 138(Pt 6):1613-28. PubMed ID: 25722288
[TBL] [Abstract][Full Text] [Related]
19. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons.
Rossini L; Villani F; Granata T; Tassi L; Tringali G; Cardinale F; Aronica E; Spreafico R; Garbelli R
Epilepsy Res; 2017 Jan; 129():146-156. PubMed ID: 28056425
[TBL] [Abstract][Full Text] [Related]
20. Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex.
Cepeda C; André VM; Hauptman JS; Yamazaki I; Huynh MN; Chang JW; Chen JY; Fisher RS; Vinters HV; Levine MS; Mathern GW
Neurobiol Dis; 2012 Jan; 45(1):310-21. PubMed ID: 21889982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
